These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 4325315)

  • 1. [Studies of genetic markers of poliovirus strains].
    Yamawaki S
    Kumamoto Igakkai Zasshi; 1970 Dec; 44(12):1165-208. PubMed ID: 4325315
    [No Abstract]   [Full Text] [Related]  

  • 2. A new type 3 attenuated poliovirus for possible use in oral poliovirus vaccine.
    Vonka V; Janda Z; Simon J; Adam E; Stárek M
    Prog Med Virol; 1967; 9():204-55. PubMed ID: 4293687
    [No Abstract]   [Full Text] [Related]  

  • 3. Evidence on the safety and efficacy of live poliomyelitis vaccines currently in use, with special reference to type 3 poliovirus.
    Bull World Health Organ; 1969; 40(6):925-45. PubMed ID: 4310724
    [No Abstract]   [Full Text] [Related]  

  • 4. [Studies on strains of poliomyelitis virus isolated in Poland during the 1959-1965 period. II. Interdependence between genetic markers of strains and their antigenic structure and neuropathological properties].
    Dobrowolska H; Stańczyk R
    Med Dosw Mikrobiol; 1966; 18(4):385-95. PubMed ID: 4289230
    [No Abstract]   [Full Text] [Related]  

  • 5. Isolation of vaccine-derived type 1 polioviruses displaying similar properties to virulent wild strain Mahoney from sewage in Japan.
    Horie H; Yoshida H; Matsuura K; Miyazawa M; Wakabayashi K; Nomoto A; Hashizume S
    J Med Virol; 2002 Nov; 68(3):445-51. PubMed ID: 12226835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative study of poliovirus excretion after vaccination of infants with two oral polio vaccines prepared on Vero cells or on primary monkey kidney cells.
    Mallet L; Pelloquin F; Brigaud M; Caudrelier P; Bandet R; Xueref C; Fuchs F; Gibelin N; Goldman C; Moulin JC; de Fraipont F; Montagnon B; Peyron L; Aymard M
    J Med Virol; 1997 May; 52(1):50-60. PubMed ID: 9131458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Studies on strains of poliomyelitis virus isolated in Poland during the 1959-1965 period. 3. Characteristics of strains isolated following the vaccination activities].
    Dobrowolska H
    Med Dosw Mikrobiol; 1966; 18(4):397-404. PubMed ID: 4289231
    [No Abstract]   [Full Text] [Related]  

  • 8. Intratypic serodifferentiation of polioviruses by comparison of neutralization indices and correlation of the antigenic marker, temperature marker and monkey neurovirulence.
    Smit GL; Wilterdink JB
    Arch Gesamte Virusforsch; 1966; 18(3):261-75. PubMed ID: 4295526
    [No Abstract]   [Full Text] [Related]  

  • 9. Poliovirus attenuation and pathogenesis in a transgenic mouse model for poliomyelitis.
    Racaniello VR; Ren R; Bouchard M
    Dev Biol Stand; 1993; 78():109-16. PubMed ID: 8388820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of type 3 poliovirus variants with increased L-cystine-dependence as live vaccines.
    Elbert LB; Chumakov MP; Krutyanskaya GL; Ralph NM; Tyufanov AV; Sokolova IS; Alpatova GA
    Arch Gesamte Virusforsch; 1971; 33(3):259-70. PubMed ID: 4329636
    [No Abstract]   [Full Text] [Related]  

  • 11. Poliomyelitis associated with type-2 poliovirus vaccine strain. Possible transmission from an immunised child to a non-immunised child.
    Stolley PD; Joseph JM; Allen JC; Deane G; Janney JH
    Lancet; 1968 Mar; 1(7544):661-3. PubMed ID: 4170650
    [No Abstract]   [Full Text] [Related]  

  • 12. Antigenic characterization of type 3 poliovirus strains isolated (1968-1970) in Italy from vaccinated and unvaccinated patients.
    Marchegiani M; Rocchi G; Santoro R; Puccinelli M
    Ann Inst Pasteur (Paris); 1971 Sep; 121(3):413-8. PubMed ID: 4108589
    [No Abstract]   [Full Text] [Related]  

  • 13. GENETIC MARKERS OF POLIOVIRUS STRAINS ISOLATED FROM PARALYTIC PATIENTS PRIOR TO AND AFTER SABIN VACCINATION PROGRAMS. I. STUDIES ON TYPE 1 STRAINS.
    FURESZ J; ARMSTRONG RE; YAROSH W; NAGLER FP
    Am J Hyg; 1964 Jul; 80():45-54. PubMed ID: 14192769
    [No Abstract]   [Full Text] [Related]  

  • 14. INTRATYPIC SERODIFFERENTIATION TESTS ON POLIO TYPE 1 VIRUS STRAINS ISOLATED BEFORE AND AFTER VACCINATION WITH ATTENUATED SABIN TYPE 1 POLIO VACCINE.
    HAHNEMANN F; SIBONI K; GODTFREDSEN A
    Acta Pathol Microbiol Scand; 1964; 61():437-45. PubMed ID: 14164891
    [No Abstract]   [Full Text] [Related]  

  • 15. Biological and antigenic analyses of newly isolated strains of Echovirus type 7.
    Oishi I; Otsu K; Kunita N
    Biken J; 1971 Jun; 14(2):141-8. PubMed ID: 5001134
    [No Abstract]   [Full Text] [Related]  

  • 16. Studies on the characteristics of Poliovirus type 3. III. Strain characteristics after passage in man.
    Jarzabek Z; Sadowski W; Kańtoch M; Magrath D; Krawczyński K
    Acta Virol; 1976 Oct; 20(5):373-9. PubMed ID: 11664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diplovax. A new oral polio vaccine.
    Med Lett Drugs Ther; 1972 Aug; 14(16):57-8. PubMed ID: 4346222
    [No Abstract]   [Full Text] [Related]  

  • 18. GENETIC MARKERS OF POLIOVIRUS STRAINS ISOLATED FROM PARALYTIC PATIENTS PRIOR TO AND AFTER SABIN VACCINATION PROGRAMS. II. STUDIES ON TYPE 3 STRAINS.
    FURESZ J; ARMSTRONG RE; MOREAU P; NAGLER FP
    Am J Hyg; 1964 Jul; 80():55-61. PubMed ID: 14192770
    [No Abstract]   [Full Text] [Related]  

  • 19. The potential use of viral genomic markers in estimating the neurovirulence of oral poliomyelitis vaccine (OPV): regulatory aspects.
    Fenyves A
    Dev Biol Stand; 1993; 78():157-9. PubMed ID: 8388826
    [No Abstract]   [Full Text] [Related]  

  • 20. Studies on characteristics of poliovirus. 3. Investigation of d, rct, h and n markers of poliovirus isolated after vaccination with the Type 1, Chat strain.
    Böttiger M
    Arch Gesamte Virusforsch; 1966; 18(2):135-54. PubMed ID: 4293025
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.